Novel imatinib derivatives with altered specificity between Bcr-Abl and FMS, KIT, and PDGF receptors. by Skobridis, K, Kinigopoulou, M, Theodorou, V, Giannousi, E, Russell, A, Chauhan, R, Sala, R, Brownlow, N, Kiriakidis, S, Domin, J, Tzakos, A, Dibb, N